Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC).

ABSTRACT:

SUBMITTER: Pitiyarachchi O 

PROVIDER: S-EPMC11921179 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature